Connect with us
[the_ad id="89560"]

Health

Thinking of taking a flu shot? Read this first…

Published

13 minute read

From the World Council For Health

It’s not just that they’re ineffective, they also cause harm. Learn about safe alternatives such as Vitamin D, quercetin and zinc.

If you’re of a certain age or demographic and in the northern hemisphere, chances are you’re being invited or encouraged to get a flu vaccine. The claim is that flu vaccines protect you and others from coming down with flu – and that if you do get it, the symptoms will be mild. So, is this true?

Many scientists see the flu shot as an unnecessary measure. For one thing, there’s a big question over whether the flu vaccine even works, particularly for older people, for whom it is recommended. Studies show that the vaccines often do not match the circulating viruses and no significant effects on serious complications or hospitalizations have been demonstrated.

You’d think that vaccinating people against flu would lead to a reduction in deaths from flu. But figures show that this isn’t the case. In fact, even though the number of flu shots given has increased more than eightfold, the number of flu-associated deaths has remained more or less unchanged.

There’s a logical explanation, and it goes like this:

Antibodies are not enough

Flu vaccines, like any other vaccine, primarily rely on the so-called Th2 antibody response. This generates antibodies to help the body fight off the influenza virus once it enters the bloodstream. What vaccines don’t do is impact the first line of defence in the nasal mucosa. This part of the innate immune system does not use antibodies, and it is here where respiratory viruses replicate.

This is why vaccines for respiratory viruses will never prevent infection or the transmission of the disease.

The immune response to vaccinations also decreases with age, which further reduces the already weak effect of vaccination in older people. Studies bear this out. In particular, a 2012 article in the British Medical Journal quoted an independent study that looked at data from 1967 to 2012 and concluded there isn’t strong evidence showing that the flu vaccine consistently protects people. While it does offer some protection for young, healthy adults who usually don’t face serious flu complications, the researchers noted that there is not enough evidence to support its effectiveness for older adults (65 and older), who account for more than 90% of flu-related deaths.

Recent research into the efficacy of flu shots also reveals their limitations

  • In 2020, Anderson et al. showed that influenza vaccination of 60 to 70 year olds in England and Wales had no discernible positive impact on hospitalization or deaths:
  • Another study in Japan reported on 83,146 individuals aged 65 years and followed them up over six years. In 2023, the incidence of hospitalization for influenza did not differ significantly by vaccination and the claimed protective effectiveness against incidence waned quickly after four or five months.
  • Another 2020 study from Anderson and team analysed data covering 170 million episodes of care and 7.6 million deaths. Turning 65 was associated with a statistically and clinically significant increase in rate of seasonal influenza vaccination. However, no evidence indicated that vaccination reduced hospitalizations or mortality among elderly persons. The study points out that estimates were precise enough to rule out results from many previous studies.

This is not just a concern for the elderly but for all those with weakened immune systems, including those undergoing immunosuppressive treatments, or individuals with chronic health conditions. In such cases, the Th2 response may not produce enough protective antibodies to effectively combat the virus, leading to a higher risk of severe illness.

Here’s another reason to exercise caution of the flu vaccine:

Flu vaccines actually SPREAD the virus

Controlled studies published in the Proceedings of the National Academy of Sciences (PNAS) find that people who receive flu shots emit 630% more flu virus particles into the air compared to non-vaccinated people. In other words, flu vaccines spread the flu!

Physicians for Informed Consent has produced this concise summary of facts that you, your loved ones and your doctor should consider before a potential injection.

All this leads to an important next question:

If the flu shot isn’t a good idea, what is?

The flu shots’ limitations make the prevention and treatment of flu with nutritional supplements like Vitamin D, Quercetin, and Zinc more appealing and safe. These supplements not only enhance the immune response but also offer additional antiviral and anti-inflammatory benefits:

Vitamin D protects the lungs and airways – and much more besides

Studies have shown that Vitamin D supplementation can significantly reduce the risk of influenza infections by enhancing the body’s immune response. It works by modulating the expression of inflammatory cytokines and increasing macrophage function, which are essential for fighting off infections.

Moreover, Vitamin D has been found to protect the lungs and airways through the antimicrobial peptide cathelicidin, which has both antibacterial and antiviral properties. Vitamin D supplementation shows promise in reducing the risk and severity of respiratory infections, including influenza. The evidence suggests that consistent Vitamin D intake can lower the incidence of acute respiratory infections, shorten the duration of symptoms, and enhance immune response, particularly in the elderly. These benefits can translate into reduced hospitalizations and deaths due to flu, making Vitamin D a valuable component in flu prevention and management strategies.

Quercetin: a powerful antiviral and zinc’s vital wingman

Quercetin is a flavonoid found in many fruits and vegetables, known for its antiviral, anti-inflammatory, and antioxidant properties. It has been shown to inhibit the entry and replication of viruses in lung cells, making it a potent candidate for managing respiratory infections like the flu. Quercetin also acts as a zinc ionophore, facilitating the transport of zinc into cells, which enhances its antiviral effects. Studies suggest that the co-administration of Quercetin and Vitamin C can exert a synergistic antiviral action, further boosting immune response and reducing viral replication

Zinc: helps prevent and reduce infection severity and duration

Zinc is an essential mineral that supports various cellular functions of both the innate and adaptive immune systems. It interferes with the process that certain cold viruses use to multiply, thereby reducing the severity and duration of infections. Zinc is particularly important for the recruitment and activity of neutrophil granulocytes, natural killer cells, and T cells, all of which play critical roles in the immune response. Supplementation with zinc has been supported by evidence showing its effectiveness in preventing viral infections and reducing their severity.

In summary…

The questionable efficiency and safety of the flu vaccine raises important concerns that cannot be overlooked. Alternative approaches such as supplementing vitamin D, quercetin and zinc, are one way to enhance immunity without the risks associated with traditional vaccinations.

Moreover, the potential for the production of IgG4 antibodies as a response to the vaccine illustrates a complex interaction between immunization and immune system dynamics, where the very act of repeated vaccination may inadvertently lead to a weakened response against certain influenza strains. This effect can also result in the weakening of the immune system in general to fight infections and cancer. This highlights the need for continued research and dialogue about the benefits and risks of flu vaccination versus alternative preventive strategies.

As we navigate through flu seasons, it is crucial to remain informed and consider individualized approaches to immune health. Ultimately, a well-rounded strategy that includes lifestyle choices, nutritional support, and an understanding of the science behind flu immunization could empower individuals to make informed decisions that best suit their health needs. The World Council for Health stands for a better way.

Please subscribe to World Council for Health.

For the full experience, upgrade your subscription.

References:

1.     Berndt, Christina: ‘Experten mit den falschen Freunden’, http://www.sueddeutsche.de/wissen/staendige-impfkommission-experten-mit-den-falschen-freunden-1.271784. 49 Arbeitsgemeinschaft Influenza: ‘Was ist die AGI?’

2.     http://influenza.rki.de/Arbeitsgemeinschaft.aspx. 50 Robert-Koch-Institut: Epidemiologisches Bulletin, 14.3.2011

3.    http://www.gpk.de/downloadp/STIKO_2011_Bulletin10_110314_Schaetzung_der_Influenza_bedingten_Todesfaelle.pdf. 51 World Health Organization: »List of Members of, and Advisor to, the International Health Regulations (2005) Emergency

4.     Committee concerning Influenza Pandemic (H1N1), 2009, http://www.who.int/ihr/emerg_comm_members_2009/en/index.html. 52 Jefferson, T.;

5.     Di Pietrantonj, C.; Rivetti, A.; Bawazeer, G.A.; Al-Ansary, L.A.; Ferroni, E.: ‘Vaccines for preventing influenza in healthy adults’, in: Cochrane Database of Systematic Reviews, 2010, 7., Art. No.: CD001269, DOI: 10.1002/14651858.CD001269.pub4.

6.     Wittig, Frank. Die weiße Mafia: Wie Ärzte und die Pharmaindustrie unsere Gesundheit aufs Spiel setzen, 2012Yan J, Grantham M, Pantelic J, Bueno de Mesquita PJ, Albert B, Liu F, Ehrman S, Milton DK; EMIT Consortium. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1081-1086. doi: 10.1073/pnas.1716561115. Epub 2018 Jan 18. PMID: 29348203; PMCID: PMC5798362.

The World Council for Health (WCH) is a grassroots, people-powered, non-profit initiative based in Bath, United Kingdom that seeks to broaden public health knowledge and sense-making through science and shared wisdom.

WCH was founded by Dr Jennifer Hibberd, a pediatric dental surgeon, and Dr Tess Lawrie, a medical doctor and former consultant to the World Health Organization, in September 2021 in response to growing distrust in local, national, and global public health authorities leaving people in fear and confused regarding how to best care for themselves, their families, and their communities.

The World Council for Health has more than 200 Coalition Partners in over 50 countries around the world and is currently in the process of decentralization, having activated more than 25 WCH Country Councils.

2025 Federal Election

Study links B.C.’s drug policies to more overdoses, but researchers urge caution

Published on

By Alexandra Keeler

A study links B.C.’s safer supply and decriminalization to more opioid hospitalizations, but experts note its limitations

A new study says B.C.’s safer supply and decriminalization policies may have failed to reduce overdoses. Furthermore, the very policies designed to help drug users may have actually increased hospitalizations.

“Neither the safer opioid supply policy nor the decriminalization of drug possession appeared to mitigate the opioid crisis, and both were associated with an increase in opioid overdose hospitalizations,” the study says.

The study has sparked debate, with some pointing to it as proof that B.C.’s drug policies failed. Others have questioned the study’s methodology and conclusions.

“The question we want to know the answer to [but cannot] is how many opioid hospitalizations would have occurred had the policy not have been implemented,” said Michael Wallace, a biostatistician and associate professor at the University of Waterloo.

“We can never come up with truly definitive conclusions in cases such as this, no matter what data we have, short of being able to magically duplicate B.C.”

Jumping to conclusions

B.C.’s controversial safer supply policies provide drug users with prescription opioids as an alternative to toxic street drugs. Its decriminalization policy permitted drug users to possess otherwise illegal substances for personal use.

The peer-reviewed study was led by health economist Hai Nguyen and conducted by researchers from Memorial University in Newfoundland, the University of Manitoba and Weill Cornell Medicine, a medical school in New York City. It was published in the medical journal JAMA Health Forum on March 21.

The researchers used a statistical method to create a “synthetic” comparison group, since there is no ideal control group. The researchers then compared B.C. to other provinces to assess the impact of certain drug policies.

Examining data from 2016 to 2023, the study links B.C.’s safer supply policies to a 33 per cent rise in opioid hospitalizations.

The study says the province’s decriminalization policies further drove up hospitalizations by 58 per cent.

“Neither the safer supply policy nor the subsequent decriminalization of drug possession appeared to alleviate the opioid crisis,” the study concludes. “Instead, both were associated with an increase in opioid overdose hospitalizations.”

The B.C. government rolled back decriminalization in April 2024 in response to widespread concerns over public drug use. This February, the province also officially acknowledged that diversion of safer supply drugs does occur.

The study did not conclusively determine whether the increase in hospital visits was due to diverted safer supply opioids, the toxic illicit supply, or other factors.

“There was insufficient evidence to conclusively attribute an increase in opioid overdose deaths to these policy changes,” the study says.

Nguyen’s team had published an earlier, 2024 study in JAMA Internal Medicine that also linked safer supply to increased hospitalizations. However, it failed to control for key confounders such as employment rates and naloxone access. Their 2025 study better accounts for these variables using the synthetic comparison group method.

The study’s authors did not respond to Canadian Affairs’ requests for comment.

 

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

 

Correlation vs. causation

Chris Perlman, a health data and addiction expert at the University of Waterloo, says more studies are needed.

He believes the findings are weak, as they show correlation but not causation.

“The study provides a small signal that the rates of hospitalization have changed, but I wouldn’t conclude that it can be solely attributed to the safer supply and decrim[inalization] policy decisions,” said Perlman.

He also noted the rise in hospitalizations doesn’t necessarily mean more overdoses. Rather, more people may be reaching hospitals in time for treatment.

“Given that the [overdose] rate may have gone down, I wonder if we’re simply seeing an effect where more persons survive an overdose and actually receive treatment in hospital where they would have died in the pre-policy time period,” he said.

The Nguyen study acknowledges this possibility.

“The observed increase in opioid hospitalizations, without a corresponding increase in opioid deaths, may reflect greater willingness to seek medical assistance because decriminalization could reduce the stigma associated with drug use,” it says.

“However, it is also possible that reduced stigma and removal of criminal penalties facilitated the diversion of safer opioids, contributing to increased hospitalizations.”

Karen Urbanoski, an associate professor in the Public Health and Social Policy department at the University of Victoria, is more critical.

“The [study’s] findings do not warrant the conclusion that these policies are causally associated with increased hospitalization or overdose,” said Urbanoski, who also holds the Canada Research Chair in Substance Use, Addictions and Health Services.

Her team published a study in November 2023 that measured safer supply’s impact on mortality and acute care visits. It found safer supply opioids did reduce overdose deaths.

Critics, however, raised concerns that her study misrepresented its underlying data and showed no statistically significant reduction in deaths after accounting for confounding factors.

The Nguyen study differs from Urbanoski’s. While Urbanoski’s team focused on individual-level outcomes, the Nguyen study analyzed broader, population-level effects, including diversion.

Wallace, the biostatistician, agrees more individual-level data could strengthen analysis, but does not believe it undermines the study’s conclusions. Wallace thinks the researchers did their best with the available data they had.

“We do not have a ‘copy’ of B.C. where the policies weren’t implemented to compare with,” said Wallace.

B.C.’s overdose rate of 775 per 100,000 is well above the national average of 533.

Elenore Sturko, a Conservative MLA for Surrey-Cloverdale, has been a vocal critic of B.C.’s decriminalization and safer supply policies.

“If the government doesn’t want to believe this study, well then I invite them to do a similar study,” she told reporters on March 27.

“Show us the evidence that they have failed to show us since 2020,” she added, referring to the year B.C. implemented safer supply.


This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.

Our content is always free – but if you want to help us commission more high-quality journalism,

consider getting a voluntary paid subscription.

Continue Reading

Addictions

Addiction experts demand witnessed dosing guidelines after pharmacy scam exposed

Published on

By Alexandra Keeler 

The move follows explosive revelations that more than 60 B.C. pharmacies were allegedly participating in a scheme to overbill the government under its safer supply program. The scheme involved pharmacies incentivizing clients to fill prescriptions they did not require by offering them cash or rewards. Some of those clients then sold the drugs on the black market.

An addiction medicine advocacy group is urging B.C. to promptly issue new guidelines for witnessed dosing of drugs dispensed under the province’s controversial safer supply program.

In a March 24 letter to B.C.’s health minister, Addiction Medicine Canada criticized the BC Centre on Substance Use for dragging its feet on delivering the guidelines and downplaying the harms of prescription opioids.

The centre, a government-funded research hub, was tasked by the B.C. government with developing the guidelines after B.C. pledged in February to return to witnessed dosing. The government’s promise followed revelations that many B.C. pharmacies were exploiting rules permitting patients to take safer supply opioids home with them, leading to abuse of the program.

“I think this is just a delay,” said Dr. Jenny Melamed, a Surrey-based family physician and addiction specialist who signed the Addiction Medicine Canada letter. But she urged the centre to act promptly to release new guidelines.

“We’re doing harm and we cannot just leave people where they are.”

Addiction Medicine Canada’s letter also includes recommendations for moving clients off addictive opioids altogether.

“We should go back to evidence-based medicine, where we have medications that work for people in addiction,” said Melamed.

‘Best for patients’

On Feb. 19, the B.C. government said it would return to a witnessed dosing model. This model — which had been in place prior to the pandemic — will require safer supply participants to take prescribed opioids under the supervision of health-care professionals.

The move follows explosive revelations that more than 60 B.C. pharmacies were allegedly participating in a scheme to overbill the government under its safer supply program. The scheme involved pharmacies incentivizing clients to fill prescriptions they did not require by offering them cash or rewards. Some of those clients then sold the drugs on the black market.

In its Feb. 19 announcement, the province said new participants in the safer supply program would immediately be subject to the witnessed dosing requirement. For existing clients of the program, new guidelines would be forthcoming.

“The Ministry will work with the BC Centre on Substance Use to rapidly develop clinical guidelines to support prescribers that also takes into account what’s best for patients and their safety,” Kendra Wong, a spokesperson for B.C.’s health ministry, told Canadian Affairs in an emailed statement on Feb. 27.

More than a month later, addiction specialists are still waiting.

 

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

 

According to Addiction Medicine Canada’s letter, the BC Centre on Substance Use posed “fundamental questions” to the B.C. government, potentially causing the delay.

“We’re stuck in a place where the government publicly has said it’s told BCCSU to make guidance, and BCCSU has said it’s waiting for government to tell them what to do,” Melamed told Canadian Affairs.

This lag has frustrated addiction specialists, who argue the lack of clear guidance is impeding the transition to witnessed dosing and jeopardizing patient care. They warn that permitting take-home drugs leads to more diversion onto the streets, putting individuals at greater risk.

“Diversion of prescribed alternatives expands the number of people using opioids, and dying from hydromorphone and fentanyl use,” reads the letter, which was also co-signed by Dr. Robert Cooper and Dr. Michael Lester. The doctors are founding board members of Addiction Medicine Canada, a nonprofit that advises on addiction medicine and advocates for research-based treatment options.

“We have had people come in [to our clinic] and say they’ve accessed hydromorphone on the street and now they would like us to continue [prescribing] it,” Melamed told Canadian Affairs.

A spokesperson for the BC Centre on Substance Use declined to comment, referring Canadian Affairs to the Ministry of Health. The ministry was unable to provide comment by the publication deadline.

Big challenges

Under the witnessed dosing model, doctors, nurses and pharmacists will oversee consumption of opioids such as hydromorphone, methadone and morphine in clinics or pharmacies.

The shift back to witnessed dosing will place significant demands on pharmacists and patients. In April 2024, an estimated 4,400 people participated in B.C.’s safer supply program.

Chris Chiew, vice president of pharmacy and health-care innovation at the pharmacy chain London Drugs, told Canadian Affairs that the chain’s pharmacists will supervise consumption in semi-private booths.

Nathan Wong, a B.C.-based pharmacist who left the profession in 2024, fears witnessed dosing will overwhelm already overburdened pharmacists, creating new barriers to care.

“One of the biggest challenges of the retail pharmacy model is that there is a tension between making commercial profit, and being able to spend the necessary time with the patient to do a good and thorough job,” he said.

“Pharmacists often feel rushed to check prescriptions, and may not have the time to perform detailed patient counselling.”

Others say the return to witnessed dosing could create serious challenges for individuals who do not live close to health-care providers.

Shelley Singer, a resident of Cowichan Bay, B.C., on Vancouver Island, says it was difficult to make multiple, daily visits to a pharmacy each day when her daughter was placed on witnessed dosing years ago.

“It was ridiculous,” said Singer, whose local pharmacy is a 15-minute drive from her home. As a retiree, she was able to drive her daughter to the pharmacy twice a day for her doses. But she worries about patients who do not have that kind of support.

“I don’t believe witnessed supply is the way to go,” said Singer, who credits safer supply with saving her daughter’s life.

Melamed notes that not all safer supply medications require witnessed dosing.

“Methadone is under witness dosing because you start low and go slow, and then it’s based on a contingency management program,” she said. “When the urine shows evidence of no other drug, when the person is stable, [they can] take it at home.”

She also noted that Suboxone, a daily medication that prevents opioid highs, reduces cravings and alleviates withdrawal, does not require strict supervision.

Kendra Wong, of the B.C. health ministry, told Canadian Affairs that long-acting medications such as methadone and buprenorphine could be reintroduced to help reduce the strain on health-care professionals and patients.

“There are medications available through the [safer supply] program that have to be taken less often than others — some as far apart as every two to three days,” said Wong.

“Clinicians may choose to transition patients to those medications so that they have to come in less regularly.”

Such an approach would align with Addiction Medicine Canada’s recommendations to the ministry.

The group says it supports supervised dosing of hydromorphone as a short-term solution to prevent diversion. But Melamed said the long-term goal of any addiction treatment program should be to reduce users’ reliance on opioids.

The group recommends combining safer supply hydromorphone with opioid agonist therapies. These therapies use controlled medications to reduce withdrawal symptoms, cravings and some of the risks associated with addiction.

They also recommend limiting unsupervised hydromorphone to a maximum of five 8 mg tablets a day — down from the 30 tablets currently permitted with take-home supplies. And they recommend that doses be tapered over time.

“This protocol is being used with success by clinicians in B.C. and elsewhere,” the letter says.

“Please ensure that the administrative delay of the implementation of your new policy is not used to continue to harm the public.”


This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.


Subscribe to Break The Needle

Launched a year ago Break The Needle provides news and analysis on addiction and crime in Canada.
Continue Reading

Trending

X